Abstract
Global health was founded on an egalitarian promise: improve health care for everyone, everywhere. As an area of research, education, and practice that leverages interdisciplinary collaboration and focuses on multinational health-care challenges and solutions,1 global health is a crucial area of discussion and development, especially to reduce the global burden of pandemics, and to promote health equity. At this crucial moment in global health with the COVID-19 pandemic exposing the weaknesses in our health systems, this Comment takes an introspective and forward-looking approach to propose actionable solutions to global health inequalities in low-income and middle-income countries (LMICs) while building relationships between high-income countries (HICs) and LMICs.
Introduction
People are adept at learning new concepts and systematically combining them with existing concepts. For example, once a child learns how to ‘skip’, they can understand how to ‘skip backwards’ or ‘skip around a cone twice’ due to their compositional skills. Fodor and Pylyshyn1 argued that neural networks lack this type of systematicity and are therefore not plausible cognitive models, leading to a vigorous debate that spans 35 years. Counterarguments to Fodor and Pylyshyn1 have focused on two main points. The first is that human compositional skills, although important, may not be as systematic and rule-like as Fodor and Pylyshyn indicated. The second is that neural networks, although limited in their most basic forms, can be more systematic when using sophisticated architectures8,9,10. In recent years, neural networks have advanced considerably and led to a number of breakthroughs, including in natural language processing. In light of these advances, we and other researchers have reformulated classic tests of systematicity and reevaluated Fodor and Pylyshyn’s arguments1. Notably, modern neural networks still struggle on tests of systematicity—tests that even a minimally algebraic mind should pass2. As the technology marches on19,20, the systematicity debate continues. In this Article, we provide evidence that neural networks can achieve human-like systematic generalization through MLC—an optimization procedure that we introduce for encouraging systematicity through a series of few-shot compositional tasks (Fig. 1). Our implementation of MLC uses only common neural networks without added symbolic machinery, and without hand-designed internal representations or inductive biases. Instead, MLC provides a means of specifying the desired behaviour through high-level guidance and/or direct human examples; a neural network is then asked to develop the right learning skills through meta-learning21.

(A) cAMP inhibition mediated by GPR1 and CMKLR1 in response to different concentrations of chemerin and C9. (B) G protein dissociation assay based on NanoBiT technology in transfected cells that express GPR1 and CMKLR1, respectively, and stimulated with chemerin and C9 at different concentrations. Control: HBSS without ligand addition. (C) IP-one accumulation in cells expressing GPR1 and CMKLR1, respectively, in response to chemerin and C9 at different concentrations. (D) β-arrestin recruitment upon chemerin and C9 stimulation based on NanoBiT technology, in transfected cells expressing GPR1 and CMKLR1, respectively. Data shown are means ± SEM from 3 independent experiments. The underlying data can be found in S1 Data.
Methods
Human GPR1 was cloned into a pFastBac vector (Invitrogen, Carlsbad, CA) for protein expression and purification. Specifically, the coding sequence of human GPR1 was fused with an N-terminal HA signal peptide followed by a FLAG tag, a human rhinovirus 14 3C (HRV-3C) protease cleavage site (LEVLFQGP) and the thermostabilized apocytochrome b(562)RIL (BRIL) fusion protein [25]. The coding sequence of human chemerin except for the last 6 amino acids was synthesized (GENERAL BIOL) and cloned into a pFastbac vector. Human dominant negative Gαi1 (DNGαi1), generated with the G203A and A326S substitution, was cloned into a pFastBac vector. N-terminal 6×His-tagged Gβ1 and Gγ2 were cloned into a pFastBac-Dual vector. scFv16 was fused with an N-terminal GP67 signal peptide and a C-terminal 8× His tag, and the coding sequence was then cloned into a pFastBac vector.

(A) cAMP inhibition mediated by GPR1 and CMKLR1 in response to different concentrations of chemerin and C9. (B) G protein dissociation assay based on NanoBiT technology in transfected cells that express GPR1 and CMKLR1, respectively, and stimulated with chemerin and C9 at different concentrations. Control: HBSS without ligand addition. (C) IP-one accumulation in cells expressing GPR1 and CMKLR1, respectively, in response to chemerin and C9 at different concentrations. (D) β-arrestin recruitment upon chemerin and C9 stimulation based on NanoBiT technology, in transfected cells expressing GPR1 and CMKLR1, respectively. Data shown are means ± SEM from 3 independent experiments. The underlying data can be found in S2 Data.
Acknowledgments
The authors thank the Kobilka Cryo-Electron Microscopy Center in the Chinese University of Hong Kong, Shenzhen, for cryo-electron microscopy analysis, and their technicians for kind help and technical support. The authors thank the Warshel Institute for Computational Biology (funding from Shenzhen City and Longgang District) for computational work.
Author Information
Authors and Affiliations
Isaac Olufadewa
*EMAIL: IsaacOlufadewa@srhin.org
AFFILIATION:Faculty of Public Health (IO) and Faculty of Clinical Sciences (MA),
College of
Medicine, University of Ibadan
Miracle Adesina
AFFILIATION:Slum and Rural Health Initiative Research Academy, Ibadan, Oyo State 200212, Nigeria
Toluwase Ayorinde
AFFILIATION: College of Medicine, and Faculty of Veterinary Medicine
Peer Review
Peer Review Information
Betta thanks Ruth Oladele and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
References
- Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282(38):28175–28188. Epub 20070716. pmid:17635925.
- Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687–4694. Epub 20070719. pmid:17640997.